BIOMEDIQ A/S: Financial statements 2013
CVR: 31176891
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
BIOMEDIQ A/S (CVR 31176891) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 5,934,540 and a net result of DKK 24,423 compared with DKK 50,652 the year before. That is a decrease of 10.6% compared with the year before. The profit margin was 0.4%. Equity in the 2013 report amounted to DKK 434,878. The solvency ratio was 12.3%.
- Revenue
- DKK 5,934,540
- Gross Profit
- DKK 3,569,742
- Profit/Loss
- DKK 24,423
- Equity
- DKK 434,878
- Total Assets
- DKK 3,534,971
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 5.9M | 3.6M | 24K | 435K | - |
| 2012 | 6.6M | 3.5M | 51K | 410K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
BIOMEDIQ A/S has published its annual report for 2012. Revenue came to DKK 6,637,825, and the net result was DKK 50,652.
About BIOMEDIQ A/S
BIOMEDIQ A/S is a Danish company of the type Aktieselskab based in København K, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYNARC IMAGING TECHNOLOGY A/S and NORDIC BIOSCIENCE IMAGING A/S. The management consists of Mads Nielsen. The board consists of Pieter Kroese (chair), Mads Nielsen and Martin Lillholm. The company is owned by Screenpoint Medical B.V. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -304,901 and a net result of DKK -977,037 compared with DKK -56,669 the year before. Equity in the 2025 report amounted to DKK -979,433.
